Leishmania Viannia guyanensis
| Autor: | Martin Olivier, Aida Minguez-Menendez, Christopher Fernandez-Prada |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Leishmaniasis Mucocutaneous 030231 tropical medicine Leishmania (Viannia) guyanensis Biology 03 medical and health sciences 0302 clinical medicine parasitic diseases Animals Humans Amastigote Leishmania guyanensis Life Cycle Stages Inoculation Health condition RNA virus biology.organism_classification Blood meal Leishmania Virology 3. Good health 030104 developmental biology Infectious Diseases Parasitology Lutzomyia Americas |
| Zdroj: | Trends in parasitology. 35(12) |
| ISSN: | 1471-5007 |
| Popis: | Leishmania of the Viannia subgenus, including Leishmania Viannia guyanensis, is the agent responsible for cutaneous and mucocutaneous leishmaniasis (CL and MCL) in the Americas from the US to Argentina. 48,000 new cases of Cl and MCL are reported yearly, among which 1/10 are associated with L. V. guyanensis infection transmitted by female Lutzomyia sandflies during the blood meal. Inoculated metacyclic promastigotes, coupled with Leishmania exosomes, will infect various inflammatory cells at inoculation sites, where they rapidly transform into amastigotes. Parasites divide and progress in the intra-macrophage form, leading to an initial CL skin ulceration. Depending on the inoculation site and host health condition, parasites may metastasize to the nasopharyngeal tissues within a few months. L. V. guyanensis is occasionally infected with Leishmania RNA virus 1 (LRV1) that can be enveloped by exosomes and is believed to accelerate MCL development. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect